Echo Point Investment Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Echo Point Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$19.2M	Sell	508,688 -18,516	-4%	-$722K	73.64%	1
2013 Q2	$20.7M	Buy	+527,204	New	+$20.5M	73.79%	1

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Echo Point Investment Management's TEVA Position: Q3 2013 in Review

Echo Point Investment Management reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 3.5% in Q3 2013, selling an estimated $722K and leaving 508,688 shares worth $19.2M. The position accounts for 73.64% of the portfolio, ranked #1.

Echo Point Investment Management first reported a position in TEVA in Q2 2013 and has held it in 2 quarters since. The position peaked at $20.7M in Q2 2013. 705 funds tracked by Wall St. Rank hold TEVA as of Q3 2013.

Echo Point Investment Management held 508,688 shares of Teva Pharmaceutical Industries Limited worth $19.2M as of Q3 2013.
Echo Point Investment Management sold 18,516 Teva Pharmaceutical Industries Limited shares in Q3 2013, an estimated $722K.
Teva Pharmaceutical Industries Limited made up 73.64% of Echo Point Investment Management's portfolio in Q3 2013, its #1 holding.
Echo Point Investment Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 2 quarters since.
Echo Point Investment Management's Teva Pharmaceutical Industries Limited position peaked at $20.7M in Q2 2013.
705 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2013.

Based on Echo Point Investment Management's 13F filing for Q3 2013, filed 5 Nov 2013.